Cargando…
Stereotactic body radiotherapy for central lung tumors: Finding the balance between safety and efficacy in the “no fly” zone
BACKGROUND: Stereotactic body radiotherapy (SBRT) has emerged as a highly effective technique to treat medically inoperable non‐small cell lung cancer (NSCLC). Doses must be chosen carefully when treating central lesions because of the potential for significant toxicity. This study reviews the outco...
Autores principales: | Ahmed, Nissar, Hasan, Shaakir, Schumacher, Lana, Colonias, Athanasios, Wegner, Rodney E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166089/ https://www.ncbi.nlm.nih.gov/pubmed/30095228 http://dx.doi.org/10.1111/1759-7714.12764 |
Ejemplares similares
-
Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series
por: Wegner, Rodney E, et al.
Publicado: (2018) -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
por: Wegner, Rodney E., et al.
Publicado: (2019) -
Image‐based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10‐year single institution experience
por: Hasan, Shaakir, et al.
Publicado: (2018) -
SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions
por: Wegner, Rodney E, et al.
Publicado: (2018) -
Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
por: Abel, Stephen, et al.
Publicado: (2019)